Evaluation of the single- and multiple-dose pharmacokinetics of fentanyl buccal soluble film in normal healthy volunteers

Journal of Clinical Pharmacology

Volumn 50, Issue 7, 2010, Pages 785-791

  Vasisht, Niraj ^a   Gever, Larry N ^b   Tagarro, Ignacio ^c   Finn, Andrew L ^a  

^a BioDelivery Sciences International Inc   (United States)

^b Meda Pharmaceuticals Inc   (United States)

^c Meda Pharmaceuticals   (Spain)

Author keywords

Buccal; Drug absorption; Fentanyl; Opioids; Pharmacokinetics; Transmucosal

Indexed keywords

FENTANYL;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DOSE COMPARISON; DRUG HALF LIFE; DRUG SAFETY; ETHNICITY; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PHASE 1 CLINICAL TRIAL; SINGLE DRUG DOSE; UNSPECIFIED SIDE EFFECT;

ADMINISTRATION, BUCCAL; ADULT; ANALGESICS, OPIOID; ANALYSIS OF VARIANCE; AREA UNDER CURVE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ELECTROCARDIOGRAPHY; FEMALE; FENTANYL; HALF-LIFE; HUMANS; MALE; NALOXONE; NARCOTIC ANTAGONISTS; NONLINEAR DYNAMICS; OXIMETRY; REPRODUCIBILITY OF RESULTS; TANDEM MASS SPECTROMETRY; YOUNG ADULT;

EID: 77953741203     PISSN: 00912700     EISSN: 15524604     Source Type: Journal    
DOI: 10.1177/0091270010361354     Document Type: Article

References (23)

1. Portenoy RK, Hagen NA Breakthrough pain: definition, prevalence and characteristics. Pain. 1990 ; 41: 273-281.
2. McCarberg BH The treatment of breakthrough pain. Pain Med. 2007 ; 8 (suppl 1). S8 - S13.
3. Zhang H., Zhang J., Streisand JB Oral mucosal drug delivery: clinical pharmacokinetics and therapeutic applications. Clin Pharmacokinet. 2002 ; 41: 661-680.
4. Inturrisi CE Clinical pharmacology of opioids for pain. Clin J Pain. 2002 ; 18 (suppl 4). S3 - S13.
5. Gutstein H., Akil H. Opioid analgesics. In: Hardman J, Limbird L, eds. Goodman and Gilmanĝ€™s the Pharmacological Basis of Therapeutics. 10 th ed. New York, NY: McGraw-Hill ; 2001: 569-619.
6. Feierman DE, Lasker JM Metabolism of fentanyl, a synthetic opioid analgesic, by human liver microsomes. Role of CYP3A4. Drug Metab Dispos. 1996 ; 24: 932-939.
7. Hanks GW, Nugent M., Higgs CM, Busch MA Oral transmucosal fentanyl citrate in the management of breakthrough pain in cancer: an open, multicentre, dose-titration and long-term use study. Palliat Med. 2004 ; 18: 698-704.
8. Streisand JB, Zhang J., Niu S., McJames S., Natte R., Pace NL Buccal absorption of fentanyl is pH-dependent in dogs. Anesthesiology. 1995 ; 82: 759-764.
9. Diaz del Consuelo I., Falson F., Guy RH, Jacques Y. Ex vivo evaluation of bioadhesive films for buccal delivery of fentanyl. J Control Release. 2007 ; 122: 135-140.
10. Darwish M., Kirby M., Robertson P., Jr., Tracewell W., Jiang JG Absolute and relative bioavailability of fentanyl buccal tablet and oral transmucosal fentanyl citrate. J Clin Pharmacol. 2007 ; 47: 343-350.
11. Actiq (fentanyl citrate) oral transmucosal lozenge [package insert]. Frazer, Pa: Cephalon ; 2007.
12. Fentora (fentanyl buccal tablet) [package insert]. Frazer, Pa: Cephalon ; 2007.
13. Vasisht N., Gever LN, Tagarro I., Finn AL Formulation selection and pharmacokinetic comparison of fentanyl buccal soluble film with oral transmucosal fentanyl citrate: a randomized, open-label, single-dose, crossover study. Clin Drug Investig. 2009 ; 29: 647-654.
14. Metropolitan Height and Weight Tables. New York, NY: Metropolitan Life Insurance Company ; 1999.
15. US Food and Drug Administration. Guidance for Industry: Statistical Approaches to Establishing Bioequivalence. Silver Spring, Md: US Food and Drug Administration ; 2001.
16. Hug CC Jr, Murphy MR Tissue redistribution of fentanyl and termination of its effects in rats. Anesthesiology. 1981 ; 55: 369-375.
17. Hug CC Jr, Murphy MR Fentanyl disposition in cerebrospinal fluid and plasma and its relationship to ventilatory depression in the dog. Anesthesiology. 1979 ; 50: 342-349.
18. Murphy MR, Olson WA, Hug CC Jr. Pharmacokinetics of 3H-fentanyl in the dog anesthetized with enflurane. Anesthesiology. 1979 ; 50: 13-19.
19. Sano T., Nishimura R., Kanazawa H., et al. Pharmacokinetics of fentanyl after single intravenous injection and constant rate infusion in dogs. Vet Anaesth Analg. 2006 ; 33: 266-273.
20. McClain DA, Hug CC Jr. Intravenous fentanyl kinetics. Clin Pharmacol Ther. 1980 ; 28: 106-114.
21. Hudson RJ, Thomson IR, Cannon JE, Friesen RM, Meatherall RC Pharmacokinetics of fentanyl in patients undergoing abdominal aortic surgery. Anesthesiology. 1986 ; 64: 334-338.
22. Vasisht N., Stark J., Finn A. Dose linearity and absolute bioavailability of BEMA (BioErodible MucoAdhesive) fentanyl in healthy volunteers. Paper presented at: 27th Annual Scientific Meeting of the American Pain Society ; May 8-10, 2008 ; Tampa, Fla.
23. Vasisht N., Stark J., Finn A. BEMA (BioErodible MucoAdhesive) fentanyl demonstrates a favorable pharmacokinetic profile compared with oral transmucosal fentanyl citrate (Actiqà) in healthy volunteers [abstract]. Pain Med. 2008 ; 9: 104.